(–)‐Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor–vascular endothelial growth factor receptor axis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Science

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1349-7006.2009.01241.xPMID 19558547PMCID PMC11158506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecularly targeted therapy for hepatocellular carcinoma

  2009cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells.

  2008cited by this paper
• Sorafenib in advanced hepatocellular carcinoma.

  2008cited by this paper
• VEGF-targeted therapy: mechanisms of anti-tumour activity

  2008cited by this paper
• EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.

  2008cited by this paper
• Molecular targeted therapies in hepatocellular carcinoma

  2008cited by this paper
• Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.

  2008cited by this paper
• EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS.

  2008cited by this paper
• (−)-Epigallocatechin Gallate Suppresses Azoxymethane-Induced Colonic Premalignant Lesions in Male C57BL/KsJ-db/db Mice

  2008cited by this paper
• Hepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1α and Stimulates the Synthesis of Vascular Endothelial Growth Factor

  2007cited by this paper
• From Molecular Biology to Targeted Therapies for Hepatocellular Carcinoma: The Future Is Now

  2007cited by this paper
• Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor.

  2007cited by this paper
• The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.

  2007cited by this paper
• Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells

  2006cited by this paper
• Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

  2006cited by this paper
• Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.

  2006cited by this paper
• Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

  2006cited by this paper
• Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.

  2006cited by this paper
• EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.

  2005cited by this paper
• Modulation of signal transduction by tea catechins and related phytochemicals.

  2005cited by this paper
• (−)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells

  2005cited by this paper
• EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.

  2005cited by this paper
• Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.

  2005cited by this paper
• Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate

  2004cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol.

  2003cited by this paper
• Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors.

  2003cited by this paper
• Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells*

  2002cited by this paper
• Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation.

  2002cited by this paper
• Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.

  2002cited by this paper
• Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway.

  2002cited by this paper
• Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.

  2002cited by this paper
• HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression

  2001cited by this paper
• EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

  2001cited by this paper
• Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastoma

  2000cited by this paper
• Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

  2000cited by this paper
• Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.

  1998cited by this paper
• Inhibition of carcinogenesis by tea

  1997cited by this paper
• Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)‐epigallocatechin gallate in human A431 epidermoid carcinoma cells

  1997cited by this paper
• Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor

  1996cited by this paper
• Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols.

  1991cited by this paper

• The interplay of exercise and green tea: a new road in cancer therapy

  2025cites this paper
• Antitumor Effects of Epigallocatechin-3-Gallate on Colorectal Cancer: An In Vitro and In Vivo Study

  2025cites this paper
• Angiogenesis as a Therapeutic Target of (Poly)phenols: Tackling Cancer and Vascular‐Related Complications

  2025cites this paper
• Research Progress on the Protective Effect of Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) on the Liver

  2025cites this paper
• (−)-Epigallocatechin-3-Gallate and Quercetin Inhibit Quiescin Sulfhydryl Oxidase 1 Secretion from Hepatocellular Carcinoma Cells

  2025influential citation
• An Update on Antitumor Efficacy of Catechins: From Molecular Mechanisms to Clinical Applications

  2025cites this paper
• Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma.

  2024cites this paper
• Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma

  2024cites this paper
• Rising potentials of epigallocatechin gallate (EGCG) loaded lipid-based delivery platforms for breast cancer

  2024cites this paper
• Grüner Tee – Daten und Studien zur chinesischen und westlichen Wirkung

  2024cites this paper
• Molecular mechanisms underlying the epigallocatechin-3-gallate-mediated inhibition of oral squamous cell carcinogenesis.

  2023cites this paper
• Anticancer Therapeutic Effects of Green Tea Catechins (GTCs) When Integrated with Antioxidant Natural Components

  2023cites this paper
• The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma

  2023influential citation
• The therapeutic effects and antioxidant properties of epigallocatechin-3 gallate: A new review

  2022cites this paper
• Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology

  2022cites this paper
• Natural Small Molecules in Gastrointestinal Tract and Associated Cancers: Molecular Insights and Targeted Therapies

  2022cites this paper
• Epigallocatechin 3-gallate: From green tea to cancer therapeutics.

  2022cites this paper
• Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis

  2022cites this paper
• Plant Natural Products: Promising Resources for Cancer Chemoprevention

  2021cites this paper
• Nutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment

  2021cites this paper
• Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway

  2021cites this paper
• The Hallmarks of Flavonoids in Cancer

  2021cites this paper
• Advances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity

  2021cites this paper
• Epigallocatechin-3-Gallate-Loaded Gold Nanoparticles: Preparation and Evaluation of Anticancer Efficacy in Ehrlich Tumor-Bearing Mice

  2020cites this paper
• A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy

  2020cites this paper
• A review on anti-cancer effect of green tea catechins

  2020cites this paper
• EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways

  2020cites this paper
• Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.

  2020cites this paper
• Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells

  2019cites this paper
• Handbook of Nutraceuticals and Functional Foods

  2019cites this paper
• A combination of Citrus reticulata peel and black tea inhibits migration and invasion of liver cancer via PI3K/AKT and MMPs signaling pathway

  2019cites this paper
• Camellia sinensis Tea and Cancer Risk: A Systematic Review

  2019cites this paper
• DNA Methylation in Anti-cancer Effects of Dietary Catechols and Stilbenoids: An Overview of Underlying Mechanisms

  2019cites this paper
• Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study

  2019cites this paper
• Epigallocatechin-3-gallate in the prevention and treatment of hepatocellular carcinoma: experimental findings and translational perspectives

  2019cites this paper
• Oolong tea: A critical review of processing methods, chemical composition, health effects, and risk

  2018cites this paper
• Possible Mechanisms of Green Tea and Its Constituents against Cancer

  2018cites this paper
• Perspectives on the recent developments with green tea polyphenols in drug discovery

  2018cites this paper
• Evaluation of Endometrial Angiogenesis in Mice Uterus Before Implantation in Natural Cycles Followed by Use of Human Menopausal Gonadotropin - Human Chorionic Gonadotropin Drugs and Epigallocatechin Gallate

  2017cites this paper
• Anti-cancer effects of naturally derived compounds targeting histone deacetylase 6-related pathways.

  2017cites this paper
• Green tea and its anti-angiogenesis effects.

  2017cites this paper
• Phytocompounds Targeting Cancer Angiogenesis Using the Chorioallantoic Membrane Assay

  2017cites this paper
• Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans-A comprehensive review.

  2017cites this paper
• Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice

  2017cites this paper
• Dendrimerized Magnetic Nanoparticles as Carriers for the Anticancer Compound, Epigallocatechin Gallate

  2016cites this paper
• Catechins and Its Role in Chronic Diseases.

  2016cites this paper
• Drug Discovery from Mother Nature

  2016cites this paper
• (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.

  2016cites this paper
• Radiological management of Hepatocellular Carcinoma

  2016cites this paper
• The Effect of Epigallocatechin Gallate on Flap Viability of Rat Perforator Abdominal Flaps

  2016cites this paper
• Chronic over-nutrition and dysregulation of GSK3 in diseases

  2016cites this paper
• Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.

  2015cites this paper
• Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma

  2015cites this paper
• (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial–mesenchymal transition via NF-κB p65 inactivation

  2015cites this paper
• Dietary Phytochemicals as Cancer Preventive Agents: Efficacy andMechanisms

  2015cites this paper
• Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma

  2015cites this paper
• Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.

  2014cites this paper
• Chemoprevention of colorectal cancer by targeting obesity-related metabolic abnormalities.

  2014cites this paper
• Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.

  2014cites this paper
• EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-7 breast cancer cells.

  2014cites this paper
• Methylated-(3′′)-Epigallocatechin Gallate Analog Suppresses Tumor Growth in Huh7 Hepatoma Cells Via Inhibition of Angiogenesis

  2014influential citation
• Catechins induced acute promyelocytic leukemia cell apoptosis and triggered PML-RARα oncoprotein degradation

  2014cites this paper
• Combination of bevacizumab and acyclic retinoid inhibits the growth of hepatocellular carcinoma xenografts.

  2014cites this paper
• Chemopreventive and hepatoprotective effects of Epigallocatechin‐gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway

  2014cites this paper
• Green Tea Polyphenols and Reduction of Oxidative Stress in Liver Cancer

  2014cites this paper
• Cellular, Molecular, and Biological Perspective of Polyphenols in Chemoprevention and Therapeutic Adjunct in Cancer 71

  2013cites this paper
• (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis

  2013cites this paper
• Identification of SLAMF3 (CD229) as an Inhibitor of Hepatocellular Carcinoma Cell Proliferation and Tumour Progression

  2013cites this paper
• Epigallocatechin-3-Gallate Inhibits IGF-I-Stimulated Lung Cancer Angiogenesis through Downregulation of HIF-1α and VEGF Expression

  2013cites this paper
• PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.

  2013cites this paper
• Phytochemicals in ocular health: Therapeutic potential and delivery challenges

  2013cites this paper
• Green Tea and Cancer Prevention

  2013cites this paper
• Molecular Aspects of Cancer Prevention by Green Tea

  2013cites this paper
• Effect of Green Tea Extract on Hepatocellular Carcinoma

  2013cites this paper
• Chemopreventive and Therapeutic Potential of Tea Polyphenols in Hepatocellular Cancer

  2013influential citation
• - Green Tea: History, Processing Techniques, Principles, Traditions, Features, and Attractions

  2013cites this paper
• Inhibitory effects of cocoa tea (Camellia ptilophylla) in human hepatocellular carcinoma HepG2 in vitro and in vivo through apoptosis.

  2012cites this paper
• Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy.

  2012cites this paper
• Cancer chemoprevention with green tea catechins: from bench to bed.

  2012cites this paper
• (-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells.

  2012cites this paper
• EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.

  2012cites this paper
• Chemoprevention of liver cancer by plant polyphenols.

  2012cites this paper
• Green tea polyphenol epigallocatechin‐3‐gallate enhances 5‐fluorouracil‐induced cell growth inhibition of hepatocellular carcinoma cells

  2012cites this paper
• (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells.

  2012cites this paper
• Combination of acyclic retinoid with branched‐chain amino acids inhibits xenograft growth of human hepatoma cells in nude mice

  2012cites this paper
• Prostanoid EP1 receptor as the target of (−)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro

  2012cites this paper
• Dietary phytochemicals in the chemoprevention and treatment of hepatocellular carcinoma: in vivo evidence, molecular targets, and clinical relevance.

  2012cites this paper
• Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease

  2011cites this paper
• Tea intake and liver diseases

  2011cites this paper
• Reply:

  2011cites this paper
• Linkage of the hepatitis C virus genotype and interleukin‐28B genetic polymorphisms in Asian patients

  2011cites this paper
• Drug‐induced autoimmune hepatitis: An easily reversible type of liver fibrosis?

  2011cites this paper
• Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis 1

  2011cites this paper
• EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

  2011cites this paper
• Chemoprevention against hepatocellular carcinoma

  2011cites this paper
• (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

  2011cites this paper
• Preventive Effects of (−)-Epigallocatechin Gallate on Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-db/db Mice

  2011cites this paper
• Inhibition of glycoprotein synthesis in the endoplasmic reticulum as a novel anticancer mechanism of (-)-epigallocatechin-3-gallate.

  2011cites this paper
• The deleterious effects of propranolol on patients with cirrhosis

  2011cites this paper
• Hyponatremia in patients treated with terlipressin: Mechanisms and implications for clinical practice

  2011cites this paper